Tension Development, Myosin Light Chain Phosphorylation and Changes in Intracellular Free [Ca2+]i Induced by α1- and α2- Adrenoceptor Agonists

  • Xiao-Fang Li
  • Bruce G. Allen
  • Michael P. Walsh
  • Chris R. Triggle
Part of the Experimental Biology and Medicine book series (EBAM, volume 26)


Vascular smooth muscle tone is regulated by a complex set of processes which vary with location of the vascular bed and the species being studied. Thus, in any synthesis of these regulatory processes, one must consider not only the effects of neurotransmitters but also vasoactive factors including hormones, locally produced substances (e.g., endothelium-derived factors) and changes in the local ionic milieu. Much emphasis has been placed on describing the effects of a specific vasoactive substance, or class of substances, on a particular vascular tissue. Much less emphasis, however, has been placed on understanding the cellular basis for the interactions (synergistic or otherwise) which occur between different vasoactive substances. To address this deficit, we are investigating the roles of α1- and α2- adrenoceptors in the regulation of vascular tone. The overall objective of this study was to determine not just the effects of individual agonists but to analyse the synergistic interactions that occur when vascular smooth muscle cells are exposed to sub-threshold concentrations of angiotensin II (ATII) prior to α-adrenergic agonists.


Tension Development Vasoactive Substance Adrenoceptor Agonist Myosin Light Chain Phosphorylation Myosin Phosphorylation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    Aburto, T.K., C. LaJoie, and K.G. Morgan. Mechanisms of signal transduction during a2 adrenergic receptor-mediated contraction of vascular smooth muscle. Circ.Res. 72: 778 - 785, 1993.PubMedCrossRefGoogle Scholar
  2. 2.
    Agrawal, D.K., C.R. Triggle, and E.E. Daniel. Pharmacological characterization of the postsynaptic alpha receptors of the rat mesenteric and canine mesenteric acteries. J. Pharmacol. Exp. Ther 299: 831 - 834, 1984.Google Scholar
  3. 3.
    Alabaster, V.A., R.F. Keir, and C.J. Peters. Comparison of activity of alpha-adrenergic agonists and antagonists in dog and rabbit saphenous vein. Naunyn. Schmiedebergs Arch. Pharmacol. 330: 33 - 36, 1985.CrossRefGoogle Scholar
  4. 4.
    Cheung, Y-D., and C.R. Triggle. Alpha adrenoceptor sites in vascular smooth muscle. Biochem. Pharmacol. 37: 4055 - 4061, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Cheung, Y-D., I. Feltham, P. Thompson, and C.R. Triggle. a-adrenoceptor activation of polyphosphoinositide hydrolysis in the rat tail artery. Biochem. Pharmacol. 40: 2425 - 2432, 1990.PubMedCrossRefGoogle Scholar
  6. 6.
    Daly, C.J., W.R. Dunn, J.C. McGrath, D.J. Miller, and V.G. Wilson. An examination of the sources of calcium for contraction mediated by post-functional al-and a2 adrenoceptors in several blood vessels isolated from the rabbit. Br. J. Pharmacol. 99: 253 - 260, 1990.PubMedCrossRefGoogle Scholar
  7. 7.
    Henrion, D., I. Laher, R. Laporte, and J.A. Bevan. Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Cat+ influx: Role of protein kinase C. J. Pharmacol exp. Ther. 261: 835 - 840, 1992.PubMedGoogle Scholar
  8. 8.
    Li, X-F., M.E. Kargacin, and C.R. Triggle. The effects of a-adrenoceptor agonists on intracellular Ca’ levels in freshly dispersed smooth muscle cells from rat tail artery. Br. J. Pharmacol. 109: 1272 - 1275, 1993.PubMedCrossRefGoogle Scholar
  9. 9.
    Li, X-F, and C.R. Triggle. Effects of pertussis and cholera toxins on a-adrenoceptor function in rat tail artery: Differences in hypertension. Can J. Physiol. Pharmacol. in press, 1994.Google Scholar
  10. 10.
    MacLean, M.R., and J.C. McGrath. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor and (endothelium-dependent) neuropeptide Y-mediated contraction in the isolated vascular bed of the rat tail. Br.J. Pharmacol.101: 205 - 211, 1990.Google Scholar
  11. 11.
    Medgett, I.C., and S.Z. Langer. Heterogeneity of smooth muscle a-adrenoceptors in the rat tail artery in vitro. J Pharmacol. exp. Ther. 229: 823 - 830, 1984.PubMedGoogle Scholar
  12. 12.
    Medgett, I.C., P.E. Hicks, and S.Z. Langer. Smooth muscle a2-adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in SHR than in WKY rat tail arteries. J. Pharmacol. exp. Ther. 231: 159 - 165, 1984.PubMedGoogle Scholar
  13. 13.
    Nielsen, H., S.McG. Thom, A.D. Hughes, C.N. Martin,M.J. Mulvavy, and P.S. Sever. Postjunctional a2 adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels. Br.J. Pharmacol. 97: 829 - 834, 1989.PubMedCrossRefGoogle Scholar
  14. 14.
    Oriowo, M.A., A.J. Nichols, and R.R. Ruffolo, Jr. Receptor protection studies with phenoxybenzamine indicate that a single a,-adrenoceptor may be coupled to two signal transduction processes in vascular smooth muscle. Pharmacology 45: 17 - 26, 1992.PubMedCrossRefGoogle Scholar
  15. 15.
    Persechini, A., K.E. Kamm, and J.F. Stull. Different phosphorylated forms of myosin in contracting tracheal smooth muscle. J. Biol. Chem. 261: 6293 - 6299, 1986.PubMedGoogle Scholar
  16. 16.
    Piascik, M.T., M.S. Sparks, T.P. Pruitt, and E.E. Soltis. Evidence for a complex interaction between the subtypes of the a,-adrenoceptor. Eur. J. Pharmacology 199: 270 - 289, 1991.CrossRefGoogle Scholar
  17. 17.
    Shi, A.G., S. Ahmad, C.Y. Kwan, and E.E. Daniel. aadrenoceptor in dog mesenteric vessels: subcellular distribution and number of [3H] prazosin and [3H] rauwolscine binding sites. J. Cardiovasc. Pharmacol. 15: 515 - 526, 1990.PubMedCrossRefGoogle Scholar
  18. 18.
    Shimamoto, H., J.-P. Bourreau, C.Y. Kwan, and E.E. Daniel. Amplification of alpha adrenergic vasoconstriction in canine mesenteric artery and vein. J. Pharmacol. exp. Ther. 260: 1119 - 1127, 1992.PubMedGoogle Scholar
  19. 19.
    Tabrizchi, R., and C.R. Triggle. Effects of staurosporine on the pressor responses to alpha-adrenoceptor agonists in pithed rats: a comparison with nifidipine. Pharmacology 43: 128 - 140, 1991.PubMedCrossRefGoogle Scholar
  20. 20.
    Tabrizchi, R., and C.R. Triggle. Pressor responses to the aadrenoceptor agonist cizoline: effects of captopril, phenoxybenzamine and nifidipine. Eur. J. Pharmacol. in press, 1993.Google Scholar
  21. 21.
    Triggle, C.R., and R. Tabrizchi. Effects of in vivo treatment with pertussis and cholera toxins on pressor effects mediated by a-adrenoceptor agonists and vasopressin: changes in hypertension. J. Vascular Medicine & Biology 3: 197 - 204, 1991.Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Xiao-Fang Li
    • 2
  • Bruce G. Allen
    • 2
    • 1
  • Michael P. Walsh
    • 2
    • 1
  • Chris R. Triggle
    • 2
  1. 1.Departments of Pharmacology & Therapeutics, and Medical BiochemistryUniversity of CalgaryCalgaryCanada
  2. 2.Faculty of MedicineUniversity of CalgaryCalgaryCanada

Personalised recommendations